These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11877294)

  • 21. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells.
    De Vos J; Jourdan M; Tarte K; Jasmin C; Klein B
    Br J Haematol; 2000 Jun; 109(4):823-8. PubMed ID: 10929036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases.
    Sengupta TK; Talbot ES; Scherle PA; Ivashkiv LB
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11107-12. PubMed ID: 9736697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation.
    Chaturvedi P; Reddy MV; Reddy EP
    Oncogene; 1998 Apr; 16(13):1749-58. PubMed ID: 9582023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6.
    Mahmoud MS; Ishikawa H; Fujii R; Kawano MM
    Blood; 1998 Nov; 92(10):3887-97. PubMed ID: 9808582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.
    Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H
    PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
    Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM
    Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activation of PKA pathway inhibits reactivity of human myeloma cell line-U266 to IL-6].
    Song J; Li Y; Shen B
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):278-80. PubMed ID: 11783106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
    Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
    Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism.
    Deo DD; Axelrad TW; Robert EG; Marcheselli V; Bazan NG; Hunt JD
    J Biol Chem; 2002 Jun; 277(24):21237-45. PubMed ID: 11940567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E1 inhibits IL-6-induced MCP-1 expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activation.
    Sobota RM; Müller PJ; Heinrich PC; Schaper F
    Biochem J; 2008 May; 412(1):65-72. PubMed ID: 18271757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells.
    Wang Y; Ripperger J; Fey GH; Samols D; Kordula T; Wetzler M; Van Etten RA; Baumann H
    Hepatology; 1999 Sep; 30(3):682-97. PubMed ID: 10462375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
    Chen T; Wang LH; Farrar WL
    Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-talk between alpha(1B)-adrenergic receptor (alpha(1B)AR) and interleukin-6 (IL-6) signaling pathways. Activation of alpha(1b)AR inhibits il-6-activated STAT3 in hepatic cells by a p42/44 mitogen-activated protein kinase-dependent mechanism.
    Nguyen VA; Gao B
    J Biol Chem; 1999 Dec; 274(50):35492-8. PubMed ID: 10585421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
    Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
    Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells.
    Hodge DR; Xiao W; Wang LH; Li D; Farrar WL
    Cancer Biol Ther; 2004 Feb; 3(2):188-94. PubMed ID: 14726660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
    Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells.
    Chauhan D; Kharbanda S; Ogata A; Urashima M; Teoh G; Robertson M; Kufe DW; Anderson KC
    Blood; 1997 Jan; 89(1):227-34. PubMed ID: 8978296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferation of immature myeloma cells by interleukin-6 is associated with CD45 expression in human multiple myeloma.
    Ishikawa H; Mahmoud MS; Fujii R; Abroun S; Kawano MM
    Leuk Lymphoma; 2000 Sep; 39(1-2):51-5. PubMed ID: 10975383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.